
Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …

A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …

The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products …

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …

Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …

This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …